We're unable to sign you in at this time. Please try again in a few minutes.
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
Other Articles |


TORALD SOLLMANN, M.D.; H. N. COLE, M.D.; KATHARINE HENDERSON, A.B.; Garrett Cooper, M.D.; Walter Schwartz, M.D.; W. R. Love, M.D.
JAMA. 1938;111(24):2175-2179. doi:10.1001/jama.1938.02790500013004.
Text Size: A A A
Published online


Intramuscular bismuth therapy against syphilis ranges between the extreme of very slow absorption from the oil suspensions of compounds that dissolve very slowly in water, such as the subsalicylate, and the other extreme of the relatively rapid absorption from watery solutions. With the watery solutions an effective concentration of bismuth in the blood and tissues is reached in a short time, perhaps after a single injection. As the excretion of these solutions is also more rapid, their action is relatively brief and they must be administered more frequently. The oil suspensions have the advantage that they may be given at longer intervals. They tend to become cumulative when injected once a week. The effective concentration in the blood is therefore approached more slowly, probably only after from two to four weeks. These extremes are bridged by a variety of bismuth preparations, such as oil suspensions of more soluble compounds and the oil-soluble compounds. It occurred to us that it might be advantageous to approach the problem in a different way, namely by an interlocking sequence of watery solutions and salicylate suspensions, adjusted to build up an effective concentration rapidly by use of the watery solution and a continuous concentration meanwhile by use of the salicylate suspension, the injections of the watery


Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

First Page Preview

View Large
First page PDF preview




Also Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Please click the checkbox indicating that you have read the full article in order to submit your answers.
Your answers have been saved for later.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.


Some tools below are only available to our subscribers or users with an online account.

0 Citations

Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

Related Content

Customize your page view by dragging & repositioning the boxes below.